PRINCE SINGH: Open Payments
NPI 1083193213 · MELVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$793 in 9 payments from 7 companies in 2025. Trend: 2023 $235 · 2024 $94 · 2025 $793
Food & beverage: $793
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $236 |
| Janssen Pharmaceuticals, Inc | 1 | $133 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Vanda Pharmaceuticals Inc. | 1 | $119 |
| ABBVIE INC. | 1 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $49 |
| Corium, LLC | 1 | $14 |
Products named: COBENFY, SPRAVATO, REXULTI, FANAPT, VRAYLAR, TRINTELLIX, Azstarys.
Industry payments across NY — which companies pay providers there.
